TIL Manufacturing Innovation at the 7th TIL Therapies Summit

Germantown, MD — November 2025 — uBriGene Biosciences Inc., a global CDMO dedicated to advancing innovation in cell and gene therapy manufacturing, is proud to announce its participation in the 7th TIL Therapies Summit, taking place November 11–13, 2025, in Boston, Massachusetts.

The summit, recognized as one of the most influential global events in tumor-infiltrating lymphocyte (TIL) research and development, brings together leading scientists, biopharmaceutical innovators, and clinicians working to transform the treatment of solid tumors.

As a first-time exhibitor at this key industry event, uBriGene will present a scientific poster titled:
“A simple end-to-end TIL manufacturing: Addressing the pain points in the complex TIL expansion process.” taking place on Thursday November 13, at 10AM 

This research highlights uBriGene’s commitment to simplifying and optimizing TIL manufacturing. By developing a streamlined, scalable, and consistent end-to-end process, the company aims to reduce complexity, enhance efficiency, and accelerate the delivery of next-generation TIL therapies to patients worldwide.

Following the first global approvals of TIL therapies, the focus has shifted toward making these promising treatments more accessible. Our integrated platform addresses key pain points in the TIL expansion process - from scalability to product consistency - enabling smoother technology transfer and faster clinical translation.

As a trusted partner in the cell and gene therapy ecosystem, uBriGene offers a comprehensive suite of manufacturing and development services spanning viral and non-viral vectors, cell therapies, and plasmid DNA. The company’s global network and automated GMP facilities empower biopharma partners to move from discovery to commercialization with speed and confidence.

uBriGene’s participation at the 7th TIL Therapies Summit underscores its dedication to advancing innovation across all therapeutic modalities and strengthening collaborations that push the boundaries of cell and gene therapy manufacturing.

Visit uBriGene's Booth to learn more about our latest developments in TIL manufacturing. Schedule a partnering meeting with our team now.